Report Detail
Global Intravenous (IV) Solutions Market Insights, Forecast to 2025
- RnM3525753 |
- 14 June, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation.
Key factors driving market expansion include the rapidly increasing natality rate including a high percentage of premature births and malnutrition.
The global Intravenous (IV) Solutions market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Intravenous (IV) Solutions market based on company, product type, end user and key regions.
This report studies the global market size of Intravenous (IV) Solutions in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intravenous (IV) Solutions in these regions.
This research report categorizes the global Intravenous (IV) Solutions market by top players/brands, region, type and end user. This report also studies the global Intravenous (IV) Solutions market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
ICU Medical Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Baxter (U.S.)
Amanta Healthcare (India)
Terumo Medical Corporation (Tokyo)
Grifols S.A. (Spain)
Market size by Product
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Market size by End User
Hospital & Clinics
Ambulatory
Home Care
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Intravenous (IV) Solutions market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Intravenous (IV) Solutions market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Intravenous (IV) Solutions companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Intravenous (IV) Solutions submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Intravenous (IV) Solutions are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intravenous (IV) Solutions market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Intravenous (IV) Solutions Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Intravenous (IV) Solutions Market Size Growth Rate by Product
- 1.4.2 Peripheral Parenteral Nutrition
- 1.4.3 Total Parenteral Nutrition
- 1.5 Market by End User
- 1.5.1 Global Intravenous (IV) Solutions Market Size Growth Rate by End User
- 1.5.2 Hospital & Clinics
- 1.5.3 Ambulatory
- 1.5.4 Home Care
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Intravenous (IV) Solutions Market Size
- 2.1.1 Global Intravenous (IV) Solutions Revenue 2014-2025
- 2.1.2 Global Intravenous (IV) Solutions Sales 2014-2025
- 2.2 Intravenous (IV) Solutions Growth Rate by Regions
- 2.2.1 Global Intravenous (IV) Solutions Sales by Regions
- 2.2.2 Global Intravenous (IV) Solutions Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Intravenous (IV) Solutions Sales by Manufacturers
- 3.1.1 Intravenous (IV) Solutions Sales by Manufacturers
- 3.1.2 Intravenous (IV) Solutions Sales Market Share by Manufacturers
- 3.1.3 Global Intravenous (IV) Solutions Market Concentration Ratio (CR5 and HHI)
- 3.2 Intravenous (IV) Solutions Revenue by Manufacturers
- 3.2.1 Intravenous (IV) Solutions Revenue by Manufacturers (2014-2019)
- 3.2.2 Intravenous (IV) Solutions Revenue Share by Manufacturers (2014-2019)
- 3.3 Intravenous (IV) Solutions Price by Manufacturers
- 3.4 Intravenous (IV) Solutions Manufacturing Base Distribution, Product Types
- 3.4.1 Intravenous (IV) Solutions Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Intravenous (IV) Solutions Product Type
- 3.4.3 Date of International Manufacturers Enter into Intravenous (IV) Solutions Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Intravenous (IV) Solutions Sales by Product
- 4.2 Global Intravenous (IV) Solutions Revenue by Product
- 4.3 Intravenous (IV) Solutions Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Intravenous (IV) Solutions Breakdown Data by End User
6 North America
- 6.1 North America Intravenous (IV) Solutions by Countries
- 6.1.1 North America Intravenous (IV) Solutions Sales by Countries
- 6.1.2 North America Intravenous (IV) Solutions Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Intravenous (IV) Solutions by Product
- 6.3 North America Intravenous (IV) Solutions by End User
7 Europe
- 7.1 Europe Intravenous (IV) Solutions by Countries
- 7.1.1 Europe Intravenous (IV) Solutions Sales by Countries
- 7.1.2 Europe Intravenous (IV) Solutions Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Intravenous (IV) Solutions by Product
- 7.3 Europe Intravenous (IV) Solutions by End User
8 Asia Pacific
- 8.1 Asia Pacific Intravenous (IV) Solutions by Countries
- 8.1.1 Asia Pacific Intravenous (IV) Solutions Sales by Countries
- 8.1.2 Asia Pacific Intravenous (IV) Solutions Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Intravenous (IV) Solutions by Product
- 8.3 Asia Pacific Intravenous (IV) Solutions by End User
9 Central & South America
- 9.1 Central & South America Intravenous (IV) Solutions by Countries
- 9.1.1 Central & South America Intravenous (IV) Solutions Sales by Countries
- 9.1.2 Central & South America Intravenous (IV) Solutions Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Intravenous (IV) Solutions by Product
- 9.3 Central & South America Intravenous (IV) Solutions by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Intravenous (IV) Solutions by Countries
- 10.1.1 Middle East and Africa Intravenous (IV) Solutions Sales by Countries
- 10.1.2 Middle East and Africa Intravenous (IV) Solutions Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Intravenous (IV) Solutions by Product
- 10.3 Middle East and Africa Intravenous (IV) Solutions by End User
11 Company Profiles
- 11.1 ICU Medical Inc. (U.S.)
- 11.1.1 ICU Medical Inc. (U.S.) Company Details
- 11.1.2 Company Business Overview
- 11.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Products Offered
- 11.1.5 ICU Medical Inc. (U.S.) Recent Development
- 11.2 B. Braun Melsungen AG (Germany)
- 11.2.1 B. Braun Melsungen AG (Germany) Company Details
- 11.2.2 Company Business Overview
- 11.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Products Offered
- 11.2.5 B. Braun Melsungen AG (Germany) Recent Development
- 11.3 Fresenius Kabi AG (Germany)
- 11.3.1 Fresenius Kabi AG (Germany) Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Products Offered
- 11.3.5 Fresenius Kabi AG (Germany) Recent Development
- 11.4 Baxter (U.S.)
- 11.4.1 Baxter (U.S.) Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Baxter (U.S.) Intravenous (IV) Solutions Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Baxter (U.S.) Intravenous (IV) Solutions Products Offered
- 11.4.5 Baxter (U.S.) Recent Development
- 11.5 Amanta Healthcare (India)
- 11.5.1 Amanta Healthcare (India) Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Amanta Healthcare (India) Intravenous (IV) Solutions Products Offered
- 11.5.5 Amanta Healthcare (India) Recent Development
- 11.6 Terumo Medical Corporation (Tokyo)
- 11.6.1 Terumo Medical Corporation (Tokyo) Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Products Offered
- 11.6.5 Terumo Medical Corporation (Tokyo) Recent Development
- 11.7 Grifols S.A. (Spain)
- 11.7.1 Grifols S.A. (Spain) Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Grifols S.A. (Spain) Intravenous (IV) Solutions Products Offered
- 11.7.5 Grifols S.A. (Spain) Recent Development
12 Future Forecast
- 12.1 Intravenous (IV) Solutions Market Forecast by Regions
- 12.1.1 Global Intravenous (IV) Solutions Sales Forecast by Regions 2019-2025
- 12.1.2 Global Intravenous (IV) Solutions Revenue Forecast by Regions 2019-2025
- 12.2 Intravenous (IV) Solutions Market Forecast by Product
- 12.2.1 Global Intravenous (IV) Solutions Sales Forecast by Product 2019-2025
- 12.2.2 Global Intravenous (IV) Solutions Revenue Forecast by Product 2019-2025
- 12.3 Intravenous (IV) Solutions Market Forecast by End User
- 12.4 North America Intravenous (IV) Solutions Forecast
- 12.5 Europe Intravenous (IV) Solutions Forecast
- 12.6 Asia Pacific Intravenous (IV) Solutions Forecast
- 12.7 Central & South America Intravenous (IV) Solutions Forecast
- 12.8 Middle East and Africa Intravenous (IV) Solutions Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Intravenous (IV) Solutions Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Intravenous (IV) Solutions. Industry analysis & Market Report on Intravenous (IV) Solutions is a syndicated market report, published as Global Intravenous (IV) Solutions Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Intravenous (IV) Solutions market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
